ELOS B — Elos Medtech AB Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Annual income statement for Elos Medtech AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	C2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	645	689	580	724	889
Cost of Revenue
Gross Profit	178	213	188	255	310
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	606	624	516	622	766
Operating Profit	38.9	65.3	63.6	101	122
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	28.5	50.6	43.3	98	99.1
Provision for Income Taxes
Net Income After Taxes	20.9	38.5	36	75.6	75
Net Income Before Extraordinary Items
Net Income	20.9	38.5	36	75.6	75
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	20.9	38.5	36	75.6	75
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.79	4.7	0.864	9.34	9.32
Dividends per Share